STATE OF OKLAHOMA
2nd Session of the 52nd Legislature (2010)
SENATE CONCURRENT
RESOLUTION 62	By:	Crain

AS INTRODUCED
A Concurrent Resolution encouraging the Medicaid Drug Utilization Review Board within the Oklahoma Health Care Authority to amend certain program; and directing distribution.

WHEREAS, the Medicaid Drug Utilization Review Board within the Oklahoma Health Care Authority is authorized by Section 5030.5 of Title 63 of the Oklahoma Statutes to recommend and implement product-based prior authorization programs for drugs or drug classes covered under the Oklahoma Medicaid program; and
WHERAS, the Oklahoma Health Care Authority Board approved a product-based prior authorization program for atypical antipsychotics at the Oklahoma Health Care Authority Board meeting on March 11, 2010; and
WHEREAS, the product-based prior authorization program for atypical antipsychotics approved by the Oklahoma Health Care Authority Board would classify atypical antipsychotic drugs into three tiers of authorization; and
WHEREAS, the product-based prior authorization program for atypical antipsychotics approved by the Oklahoma Health Care Authority Board would require some persons on Medicaid to undergo a fourteen-day trial of one Tier One medication and all Tier Two medications before advancing to a Tier Three medication; and
WHEREAS, atypical antipsychotics are used to used to treat psychiatric conditions, including schizophrenia, acute mania, bipolar mania and psychotic agitation; and
WHEREAS, delaying the prescription of more effective medications to persons with a serious psychiatric condition could have a negative effect on their health.
NOW, THEREFORE, BE IT RESOLVED BY THE SENATE OF THE 2ND SESSION OF THE 52ND OKLAHOMA LEGISLATURE, THE HOUSE OF REPRESENTATIVES CONCURRING THEREIN:
THAT the Legislature encourages the Medicaid Drug Utilization Review Board within the Oklahoma Health Care Authority to amend the product-based prior authorization program for atypical antipsychotic medications to require a trial of only one drug per tier before authorizing an atypical antipsychotic in a higher tier.
THAT the Secretary of State shall distribute a copy of this resolution to the Oklahoma Health Care Authority Board.

52-2-3951	JM	5/10/2010 11:30:46 AM